• No image available for this medication
    • CIMERLI

RANIBIZUMAB (RA ni BIZ oo mab) treats eye conditions, such as macular degeneration, macular edema, and retinopathy. It works by slowing the growth of abnormal new blood vessels in the eye. It also reduces the amount of fluid that leaks from these blood vessels. This helps maintain vision. It is a monoclonal antibody.


What does CIMERLI look like?

View images of CIMERLI and identify pills by imprint, color or shape. If you need to save money on your CIMERLI, compare our prices. Our prescription savings may even be lower than your insurance copay!

Note: Multiple images may be displayed for medicines available in different strengths, sold under different brand names, or manufactured by different pharmaceutical companies.

CIMERLI 0.5mg/0.05mL for Inj
CIMERLI 0.5mg/0.05mL for Inj

Strength: 0.5MG/0.05

Pill Imprint:

Color:

Shape:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.